Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization

por Li, Yujia, Parks, Griffith D.
Publicado 2018

Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus

por Kedarinath, Kritika, Parks, Griffith D.
Publicado 2022

An AGM Model for Changes in Complement during Pregnancy: Neutralization of Influenza Virus by Serum Is Diminished in Late Third Trimester

por Mayer, Anne E., Parks, Griffith D.
Publicado 2014

Histone Deacetylase Inhibitors Enhance Cell Killing and Block Interferon-Beta Synthesis Elicited by Infection with an Oncolytic Parainfluenza Virus

por Fox, Candace R., Parks, Griffith D.
Publicado 2019

La Crosse Virus Infection of Human Keratinocytes Leads to Interferon-Dependent Apoptosis of Bystander Non-Infected Cells In Vitro

por Cruz, Maria A., Parks, Griffith D.
Publicado 2020

Complement Inhibitors Vitronectin and Clusterin Are Recruited from Human Serum to the Surface of Coronavirus OC43-Infected Lung Cells through Antibody-Dependent Mechanisms

por Fox, Candace R., Parks, Griffith D.
Publicado 2021

DNA methyltransferase inhibitor 5-azacytidine enhances neuroblastoma cell lysis by an oncolytic parainfluenza virus

por Kedarinath, Kritika, Shiffer, Elisabeth M., Parks, Griffith D.
Publicado 2023

Oncolytic parainfluenza virus combines with NK cells to mediate killing of infected and non-infected lung cancer cells within 3D spheroids: role of type I and type III interferon s...

por Varudkar, Namita, Oyer, Jeremiah L, Copik, Alicja, Parks, Griffith D
Publicado 2021

Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5

por Capraro, Gerald A., Johnson, John B., Kock, Nancy D., Parks, Griffith D.
Publicado 2008

Delivery of a novel membrane-anchored Fc chimera enhances NK cell-mediated killing of tumor cells and persistently virus-infected cells

por Varudkar, Namita, Shiffer, Elisabeth M., Oyer, Jeremiah L., Copik, Alicja, Parks, Griffith D.
Publicado 2023

Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge

por Clark, Kimberly M., Johnson, John B., Kock, Nancy D., Mizel, Steven B., Parks, Griffith D.
Publicado 2011

Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24

por Mazar, Joseph, Li, Yujia, Rosado, Amy, Phelan, Peter, Kedarinath, Kritika, Parks, Griffith D., Alexander, Kenneth A., Westmoreland, Tamarah J.
Publicado 2018

CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection

por Kedarinath, Kritika, Fox, Candace R., Crowgey, Erin, Mazar, Joseph, Phelan, Peter, Westmoreland, Tamarah J., Alexander, Kenneth A., Parks, Griffith D.
Publicado 2022

Broad-Spectrum, Potent, and Durable Ceria Nanoparticles Inactivate RNA Virus Infectivity by Targeting Virion Surfaces and Disrupting Virus–Receptor Interactions

por Fox, Candace R., Kedarinath, Kritika, Neal, Craig J., Sheiber, Jeremy, Kolanthai, Elayaraja, Kumar, Udit, Drake, Christina, Seal, Sudipta, Parks, Griffith D.
Publicado 2023

ALD based nanostructured zinc oxide coated antiviral silk fabric

por Kumar, Udit, Fox, Candace R., Feit, Corbin, Kolanthai, Elayaraja, Sheiber, Jeremy, Fu, Yifei, Singh, Sushant, Banerjee, Parag, Parks, Griffith D., Seal, Sudipta
Publicado 2022

Aptamer–gold nanoparticle conjugates for the colorimetric detection of arboviruses and vector mosquito species

por Bosak, Alexander, Saraf, Nileshi, Willenberg, Alicia, Kwan, Michael W. C., Alto, Barry W., Jackson, George W., Batchelor, Robert H., Nguyen-Huu, Truong D., Sankarapani, Vinoth, Parks, Griffith D., Seal, Sudipta, Willenberg, Bradley Jay
Publicado 2019